The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX

AIMS: To assess whether the use of the femoral or radial approach for percutaneous coronary intervention (PCI) interacted with the efficacy and safety of cangrelor, an intravenous P2Y(12) inhibitor, in CHAMPION PHOENIX. METHODS AND RESULTS: A total of 11 145 patients were randomly assigned in a doub...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Eur Heart J
Hoofdauteurs: Gutierrez, J. Antonio, Harrington, Robert A., Blankenship, James C., Stone, Gregg W., Steg, Ph. Gabriel, Gibson, C. Michael, Hamm, Christian W., Price, Matthew J., Généreux, Philippe, Prats, Jayne, Deliargyris, Efthymios N., Mahaffey, Kenneth W., White, Harvey D., Bhatt, Deepak L., Bhatt, DL, Stone, GW, Mahaffey, KW, Gibson, CM, Steg, PG, Hamm, CW, Price, MJ, Leonardi, S, Gallup, D, Bramucci, E, Radke, PW, Widimsky, P, Tousek, F, Tauth, J, Spriggs, D, McLaurin, BT, Angiolillo, DJ, Genereux, P, Liu, T, Prats, J, Todd, M, Skerjanec, S, White, HD, Harrington, RA
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2016
Onderwerpen:
FASTTRACK ESC Clinical Trial Update
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4823635/
https://ncbi.nlm.nih.gov/pubmed/26400827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv498
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items